Laidlaw Reiterates Buy Rating on IN8bio Inc. (INAB)
Tweet Send to a Friend
Laidlaw analyst Yale Jen reiterated a Buy rating and $7.50 price target on IN8bio Inc. (NASDAQ: INAB).The analyst commented, "Yesterday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
